Answers are grounded in this paper and cite their sources.
Demonstrates a surface plasmon resonance biosensor assay for profiling human CYP51A1 binding, highlighting its utility in screening novel steroid and triterpene ligands.
The SPR-based test for human cytochrome P450 51A1 (CYP51A1) ligand screening has been developed. Applicability of this system has been validated with known azole inhibitors of cytochromes P450. The studied azoles selectively interacted with human cytochrome P450 51A1, which showed the highest affinity towards ketoconazole. The efficiency of the SPR based assay has been tested using 19 steroid and triterpene compounds, which have not been investigated as potential ligands of CYP51A1.
No takes yet. Share an insight, caveat, or question.
Gnedenko et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: